CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Potassium chloride powder +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02653560
NCT02653560Phase 4Completed

Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension

University of Texas Southwestern Medical Center·interventional·Posted Jan 12, 2016·Updated Oct 16, 2023

In Brief

A Phase 4 clinical trial evaluating Potassium chloride powder, Potassium magnesium Citrate (KMgCit), and 2 other interventions for Hypertension. Completed, enrolled 30 participants across 1 site.

Detailed Summary

In the DASH (Dietary Approaches to Stop Hypertension) trials, a diet rich in fruits, vegetables, nuts and dairy products, and limited in fat content, was shown to be useful in controlling hypertension. Key components of such a diet are potassium, magnesium and alkali, each of which has been implicated in lowering blood pressure. Whether a liquid formulation of potassium-magnesium citrate will result in equivalent BP effect as the DASH diet is unknown.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 12, 2016
Enrollment StartSep 1, 2012
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.5 years ago

Interventions

Potassium chloride powderdrug

Potassium magnesium Citrate (KMgCit)drug

Potassium citrate powderdrug

Placebodrug